Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  7.50 8.33% 97.50 95.00 100.00 99.00 90.00 90.00 116,009 15:24:51
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -0.6 -4.7 - 16

Aortech Share Discussion Threads

Showing 8726 to 8749 of 8750 messages
Chat Pages: 350  349  348  347  346  345  344  343  342  341  340  339  Older
DateSubjectAuthorDiscuss
25/5/2020
12:24
https://www.telegraph.co.uk/health-fitness/body/pioneering-heart-surgery-saved-life-lockdown/ A very recent patient's story of having a TAVI fitted. AOR is not quite at the TAVI stage but, after the recent developments, this will be next in line for design. https://www.youtube.com/watch?v=3YCMlrPNH_U The above is an Edwards video. In the telegraph article it is interesting that the figure of £20k is mentioned. 'Twelve hours after the operation I walked out of the hospital, a new organic £20,000 valve pumping inside my heart, with the promise I could start jogging again soon.'
langland
22/5/2020
15:41
Fortunately, heart valves are not short term devices. Long term target = the sky. Some short termers are bailing today, so it should get the share register firmer with new blood that looks further than a three day profit!
bones
22/5/2020
15:06
chart looks v positive. S-t target of around 130p
t0pgrader
22/5/2020
13:26
Yes, I agree. This is a company offering disruptive medical tech which already has a captive audience and customers that it applies to.
greedy rooster
22/5/2020
12:39
Will soon be breaking out to new highs imo.
someuwin
22/5/2020
11:27
Looking good, bought another chunk...
bigwig
22/5/2020
10:50
Landy, well, I guess it’s only 1% of the company!
bones
22/5/2020
10:44
Well CEO bought at one quid (Rua Sell) and we've had excellent progress since. This should be well above what David bought at.
nimbo10
22/5/2020
10:39
Bones, it depends where the warrants sit now, if in a drawer in corporate then yes they keep faith with the client, if with the MM, then you can be more relaxed about a short position, shake the trees, cover your position and do it again at the next level up. It will act as a break on the rise but absorb a few shocks in the road along the way.
landy90
22/5/2020
10:35
Can currently get a buy quote for £4k. But not for £5k.
someuwin
22/5/2020
10:28
Ok Someuwin - thanks
t0pgrader
22/5/2020
10:28
Depends if Shore get short of dosh?
semper vigilans
22/5/2020
10:22
Landy90, if Shore Capital have any faith in their client, they will surely hold firm for another three years and cash in a monster bonus!
bones
22/5/2020
10:07
The break of the 96 resistance may get some technical analysis types interested because it looks to me that we have a slightly lopsided inverse head and should shoulders which would give a target of about 130+. DYOR
langland
22/5/2020
09:50
Sorry, No real idea on timescales t0pgrader. I'm just going to keep holding (and sometimes adding) as things develop. Or until they get bought out.
someuwin
22/5/2020
09:42
>>someuwin when might you expect the company to lay out the timetable for CE marking / FDA approval? Thanks
t0pgrader
22/5/2020
09:41
Someuwin, good to remind us of that. Those are also the same vesting terms that apply to the options held by Bill Brown and John McKenna (albeit theirs are at 30p being the placing price at the time), granted at the June 2018 placing. Therefore, all of the active board members are completely aligned.
bones
22/5/2020
09:39
someuwin the visibility of progress is very important £3 would do me !!!
parsons4
22/5/2020
09:36
I'm more interested in the options vesting criteria... 1. 20 per cent of the Options granted vest after 3 years. 2. 30 per cent upon the Group receiving either CE Marking or FDA approval for one of its devices in development. 3. The balance of 50 per cent on the Company's share price being at least GBP3.00 per share for ten consecutive trading days. ...These options (with an exercise price of 92.5p) were granted in December last year so they had good visibility of progress and must have been confident that they will achieve these targets. Which will come first I wonder? CE marking / FDA approval or share price of £3. My guess it that when we get the former, the latter will be well in excess of £3.
someuwin
22/5/2020
09:03
One would hope that if and when exercised, they would be placed sensibly without disturbing the market. Cash for the company too.
semper vigilans
22/5/2020
08:56
Warrants Warrants were awarded to Shore Capital (nominated adviser) in lieu of £50,000 of fees due in connection with the placing of new shares in June 2018. The warrant was priced at £1 and entitles the holder to purchase 166,667 ordinary shares at a price of £0.30 per ordinary share. The warrant can be exercised at any time prior to the expiry date, which is 5 years post the date of grant. From last years accounts, explains why one market maker is prepared to hold firm!
landy90
22/5/2020
08:28
Won't let me buy many.
someuwin
22/5/2020
08:22
Agreed. They're going to have to let these go soon.
greedy rooster
22/5/2020
06:38
We have said it a million times here alone, the ridiculous spread puts investors off. Yes sometimes you can get within the spread and quite often you can not. Quite right in what you say though, 90.5p was selling price late yesterday afternoon, so a tick up on any buys should happen today.
cocker
Chat Pages: 350  349  348  347  346  345  344  343  342  341  340  339  Older
ADVFN Advertorial
Your Recent History
LSE
AOR
Aortech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200525 12:16:04